Gyon Technologies Capital Management, LP Agenus Inc Transaction History

Gyon Technologies Capital Management, LP

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Feb 11, 2022	SELL	$2.92 - $5.74 $186,214 - $366,051	-63,772 Closed	0 $0
Q3 2021 Nov 18, 2021	SELL	$4.98 - $6.63 $1.08 Million - $1.44 Million	-217,561 Reduced 77.33%	63,772 $335,000
Q2 2021 Aug 16, 2021	BUY	$2.56 - $5.49 $613,440 - $1.32 Million	239,625 Added 574.53%	281,333 $1.55 Million
Q1 2021 May 17, 2021	BUY	$2.69 - $5.25 $112,194 - $218,967	41,708 New	41,708 $113,000

2.07M

Ticker AGEN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 283,163,008
Market Cap $4.73B
Description
Agenus Inc., a clinical-stage immuno-oncology company, discovers and develops immuno-oncology products in the United States and internationally. The company offers Retrocyte Display, an antibody expression platform for the identification of fully human and humanized monoclonal antibodies; and display technologies. It develops vaccine programs co...

Get notified when there are updates to the investment portfolio of Gyon Technologies Capital Management, LP, based on Form 13F filings with the SEC.

Stay updated on Gyon Technologies Capital Management, LP with notifications on news.